Center-Authored Papers

Filters: Author is Tsao, Anne S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Public Health Sciences Division
Garland LL, Chansky K, Wozniak AJ, Tsao AS, Gadgeel SM, Verschraegen CF, Dasilva MA, Redman MW, Gandara DR.  2011.  Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(11):1938-45. Abstract
Tsao AS, Garland L, Redman MW, Kernstine K, Gandara D, Marom EM.  2011.  Reply to the Letter to the Editor Entitled A Practical Guide to Measure "All" Malignant Pleural Mesothelioma Tumors by Modified RECIST Criteria? Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(12):2144-5.
October 2011
Garland LL, Chansky K, Wozniak AJ, Tsao AS, Gadgeel SM, Verschraegen CF, Dasilva MA, Redman MW, Gandara DR.  2011.  Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(11):1938-45. Abstract
December 2011
Tsao AS, Garland L, Redman MW, Kernstine K, Gandara D, Marom EM.  2011.  Reply to the Letter to the Editor Entitled A Practical Guide to Measure "All" Malignant Pleural Mesothelioma Tumors by Modified RECIST Criteria? Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(12):2144-5.
Center-Authored Paper
Garland LL, Chansky K, Wozniak AJ, Tsao AS, Gadgeel SM, Verschraegen CF, Dasilva MA, Redman MW, Gandara DR.  2011.  Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(11):1938-45. Abstract
2011
Tsao AS, Garland L, Redman MW, Kernstine K, Gandara D, Marom EM.  2011.  Reply to the Letter to the Editor Entitled A Practical Guide to Measure "All" Malignant Pleural Mesothelioma Tumors by Modified RECIST Criteria? Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(12):2144-5.
Garland LL, Chansky K, Wozniak AJ, Tsao AS, Gadgeel SM, Verschraegen CF, Dasilva MA, Redman MW, Gandara DR.  2011.  Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(11):1938-45. Abstract